Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human |
Host species | Goat |
Applications | ELISA,WB-Ti |
Brand: | Abnova |
Reference: | PAB13670 |
Product name: | DLX5 polyclonal antibody |
Product description: | Goat polyclonal antibody raised against synthetic peptide of DLX5. |
Gene id: | 1749 |
Gene name: | DLX5 |
Gene alias: | - |
Gene description: | distal-less homeobox 5 |
Immunogen: | A synthetic peptide corresponding to amino acids at internal region of human DLX5. |
Immunogen sequence/protein sequence: | C-AYNRVPSATNQPEK |
Protein accession: | NP_005212.1 |
Form: | Liquid |
Concentration: | 0.5 mg/mL |
Recommend dilutions: | ELISA (1:32000) Western Blot (1-3 ug/mL) The optimal working dilution should be determined by the end user. |
Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Goat |
Antigen species / target species: | Human |
Specificity: | Approximately 30 KDa band observed in human bone marrow lysates (calculated MW of 31.5 KDa according to NP_005212.1). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Lee et al, J Biol Chem. 2003 Sep 5;278(36):34387-94; PMID: 12815054). |
Reactivity: | Human |
Application image: | ![]() |
Application image note: | DLX5 polyclonal antibody (Cat # PAB13670) (1 ug/mL) staining of human bone marrow lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
Applications: | ELISA,WB-Ti |
Shipping condition: | Dry Ice |
Publications: | A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.Tan Y, Timakhov RA, Rao M, Altomare DA, Xu J, Liu Z, Gao Q, Jhanwar SC, Di Cristofano A, Wiest DL, Knepper JE, Testa JR. Cancer Res. 2008 Mar 1;68(5):1296-302. |